Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
Pharmacology, Toxicology and Pharmaceutical Science
1
17%
Agricultural and Biological Sciences
1
17%
Chemistry
1
17%
Medicine and Dentistry
1
17%
Unknown
2
33%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2024.
All research outputs
#18,838,899
of 27,329,964 outputs
Outputs from Cancer Letters
#4,590
of 6,385 outputs
Outputs of similar age
#149,731
of 292,188 outputs
Outputs of similar age from Cancer Letters
#20
of 35 outputs
Altmetric has tracked 27,329,964 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,385 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,188 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
